Results 1 - 8 of 8 for tendon within all areas of the EPA. Only web pages are included. Search all document formats.

New Gene Discovered For Recessive Form of Brittle Bone Disease01-21-2010
Collagen functions as molecular scaffolding that holds together bone, tendons, skin and other tissues. Most types of osteogenesis imperfecta result ...
http://www.epa.gov/aging/press/othernews/2010/2010_0120_ons_2.htm (HTML)
2007 Small Business Award | Green Chemistry | US EPA04-01-2007
... materials including: (a) musculoskeletal allograft tissue (e.g., human bone, tendons, dermis, and heart valves) for transplantation; (b) biodegradable polymers and ...
http://www.epa.gov/greenchemistry/pubs/pgcc/winners/sba07.html (HTML)
Final Report | Determine and Confirm the Field Use Protocol for NanoProtectâ„¢ Nontoxic Decontaminate for Facilities and Equipment Following a Bioincident09-10-2006
Nanoemulsion was effective in decontamination of bone and tendon transplant extracted from cadavers and used for human allograft tissues. The ...
http://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstr... (HTML)
IRIS Summary of Mercury, Elemental (CASRN 7439-97-6)01-21-2010
"This is a summary of information on Mercury, Elemental (CASRN 7439-97-6) provided by the Integrated Risk Information System (IRIS)."
http://www.epa.gov/NCEA/iris/subst/0370.htm (HTML)
Mercury, elemental (CASRN 7439-97-6) | IRIS | US EPA01-21-2010
Also observed were eyelid fasciculation, hyperactive deep-tendon reflexes and dermatographia, but there was no correlation between the incidence of ...
http://www.epa.gov/IRIS/subst/0370.htm (HTML)
Mercury, elemental (CASRN 7439-97-6) | IRIS | US EPA07-09-2009
Also observed were eyelid fasciculation, hyperactive deep-tendon reflexes and dermatographia, but there was no correlation between the incidence of ...
http://www.epa.gov/ncea/iris/subst/0370.htm (HTML)
Final Draft, Meeting Summary Report: ICR, Treatment, and Methods Research Stakeholder Meeting For The Stage 2 DBPR and LT2ESWTR11-28-2006
"This is the agenda for this meeting."
http://www.epa.gov/safewater/mdbp/st2mar99.html (HTML)
EPA ICR, Treatment, and Methods Research Stakeholder Meeting For The Stage 2 DBPR and LT2ESWTR11-28-2006
Final Draft Meeting Summary Report ICR, Treatment, and Methods Research Stakeholder Meeting For The Stage 2 DBPR and LT2ESWTR March 10-12, 1999 Hyatt Arlington at Washington's Key Bridge Arlington, VA Prepared by: ISSI Consulting Group, Inc. 8455 Colesville Road Suite 915 Silver Spring, MD 20910 Prepared for: U.S. Environmental Protection Agency Office of Water Health and Ecological Criteria Division 401 M.
http://www.epa.gov//safewater/mdbp/st2mar99.html (HTML)

Jump to main content.